Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

69
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
69
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

121
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
121
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

902
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
902
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

80
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
80
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Pharmacotherapy in Reducing the Inflammation Process of Spinal Cord Injuries: A Systematic Review of Animal Studies.

TheScientificWorldJournal·2024
Same author

Surgery for subaxial cervical spine injuries: which is better: anterior, posterior, or anterior-posterior combined approach?: a systematic review and meta-analysis.

Asian spine journal·2024
Same author

Diagnosis and Prevalence (1975-2010) of Sudden Death due to Atlantoaxial Subluxation in Cervical Rheumatoid Arthritis: A Literature Review.

TheScientificWorldJournal·2023
Same author

Case of compressive myelopathy due to juvenile xanthogranuloma of cervicothoracic junction in a 28-year-old male.

Surgical neurology international·2023
Same author

Clustering models for hospitals in Jakarta using fuzzy c-means and k-means.

Procedia computer science·2023
Same author

A BERTweet-based design for monitoring behaviour change based on five doors theory on coral bleaching campaign.

Journal of big data·2022

Related Experiment Video

Updated: Aug 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Towards a more general drug target interaction prediction model using transfer learning.

Derwin Suhartono1, Muhammad Rizki Nur Majiid1, Alif Tri Handoyo1

  • 1Computer Science Department, School of Computer Science, Bina Nusantara University, Jakarta, Indonesia 11480.

Procedia Computer Science
|January 16, 2023
PubMed
Summary
This summary is machine-generated.

Transfer learning enhances drug-target interaction (DTI) prediction. Using a CNN model pre-trained on BindingDB data significantly improves DTI prediction accuracy on new datasets like DAVIS.

Keywords:
SMILESdeep learningdrug discoverydrug-target interactiontransfer learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

834

Related Experiment Videos

Last Updated: Aug 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

834

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Artificial intelligence

Background:

  • Drug-target interaction (DTI) is crucial for discovering new disease treatments.
  • Artificial intelligence (AI) is increasingly applied to DTI prediction.
  • Transfer learning's potential in DTI prediction remains underexplored.

Purpose of the Study:

  • To develop a more generalizable DTI prediction model using transfer learning.
  • To investigate the effectiveness of CNN, RNN, and Transformer models in DTI prediction via transfer learning.

Main Methods:

  • Tested CNN, RNN, and Transformer models for DTI prediction.
  • Utilized two public DTI datasets: BindingDB and DAVIS.
  • Implemented transfer learning by pre-training models on one dataset and fine-tuning on another.

Main Results:

  • The CNN model pre-trained on BindingDB demonstrated superior performance.
  • Fine-tuning the BindingDB pre-trained model on the DAVIS dataset resulted in a 6% increase in AUPRC compared to models without pre-training.

Conclusions:

  • A CNN model pre-trained on BindingDB is recommended for general DTI prediction tasks.
  • Transfer learning significantly boosts DTI prediction performance, especially when adapting models to new biological contexts.